NMDA receptor activation inhibits the anti-fibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis
2018
Endogenous glutamate (Glu) release and N-methyl-D-aspartate (NMDA) receptor (NMDAR) activation are associated with lung injury in different animal models. However, the underlying mechanism is unclear. Bone marrow-derived mesenchymal stem cells (BM-MSCs), which show potential use for immunomodulation and tissue-protection, play a protective role in pulmonary fibrosis (PF) process. Here, we found the increased Glu release from the BM cells of bleomycin (BLM)-induced PF mice in vivo. BLM stimulation also increased the extracellular Glu in BM-MSCs via the antiporter system xc- in vitro. The gene expression of each subunit of NMDAR was detected in BM-MSCs. NMDAR activation inhibited the proliferation, migration, and paracrine function of BM-MSCs in vitro. BM-MSCs were derived from male C57BL/6 mice, transfected with lentiviral vectors carrying the enhanced green fluorescence protein (eGFP) gene, pretreated with NMDA, and transplanted into the female recipient mice that were intratracheally injected with BLM to...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
74
References
9
Citations
NaN
KQI